Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 3c

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.39), $0.03 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $4.37 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters